Literature DB >> 19751169

Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.

Jill Beech1, Raymond C Boston, Dianne McFarlane, Sue Lindborg.   

Abstract

OBJECTIVE: To measure plasma ACTH, alpha-melanocyte-stimulating hormone (aloha-MSH), and insulin concentrations during various photoperiods between February and October in horses and ponies with and without pituitary pars intermedia dysfunction (PPID).
DESIGN: Cohort study. ANIMALS: 13 clinically normal (control) ponies, 14 clinically normal (control) horses, 7 ponies with PPID, and 8 horses with PPID. PROCEDURES: Blood samples were collected from February through October during 8 photoperiods: 1, February 13 through March 2; 2, April 4 through 6; 3, June 19 through 22; 4, August 6 through 7; 5, August 14 through 17; 6, September 4 through 6; 7, September 26 through 28; and 8, October 16 through 18. Plasma ACTH, alpha-MSH, and insulin concentrations at each photoperiod were compared among groups.
RESULTS: Log ACTH concentration was increased during photoperiod 4 through 8, compared with photoperiod 1 through 3, in all groups. In photoperiod 3 through 7, log ACTH concentrations were higher in horses and ponies with PPID, compared with values for control horses and ponies. alpha-Melanocyte-stimulating hormone (log and raw value) concentration was higher in photoperiod 2 through 8, compared with photoperiod 1, in control horses and ponies. In horses and ponies with PPID, log alpha-MSH concentration was higher in photoperiod 3 through 8, and alpha-MSH concentration was higher in photoperiod 4 through 8, compared with photoperiod 1. In control horses and ponies, plasma insulin concentration was lower in photoperiod 3 than in photoperiod 1. CONCLUSIONS AND CLINICAL RELEVANCE: Plasma alpha-MSH and ACTH concentrations increased as daylight decreased from summer solstice (maximum daylight hours) to 12 hours of daylight.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751169     DOI: 10.2460/javma.235.6.715

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  14 in total

1.  Relationship of skeletal muscle inflammation with obesity and obesity-associated hyperinsulinemia in horses.

Authors:  Heidi E Banse; Todd C Holbrook; Nicholas Frank; Dianne McFarlane
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

2.  Assessing the seasonal prevalence and risk factors for nuchal crest adiposity in domestic horses and ponies using the Cresty Neck Score.

Authors:  Sarah L Giles; Christine J Nicol; Sean A Rands; Patricia A Harris
Journal:  BMC Vet Res       Date:  2015-01-31       Impact factor: 2.741

3.  Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses.

Authors:  K A Hart; D M Wochele; N A Norton; D McFarlane; A A Wooldridge; N Frank
Journal:  J Vet Intern Med       Date:  2016-02-09       Impact factor: 3.333

4.  The Effect of Geographic Location on Circannual Adrenocorticotropic Hormone Plasma Concentrations in Horses in Australia.

Authors:  C J Secombe; R H H Tan; D I Perara; D P Byrne; S P Watts; J G Wearn
Journal:  J Vet Intern Med       Date:  2017-06-29       Impact factor: 3.333

5.  Effect of thyrotropin-releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol.

Authors:  Elizabeth Hodge; Alycia Kowalski; Catherine Torcivia; Sue Lindborg; Darko Stefanovski; Kelsey Hart; Nicholas Frank; Andrew van Eps
Journal:  J Vet Intern Med       Date:  2019-08-20       Impact factor: 3.333

6.  The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses.

Authors:  Ke Hu; Allison J Stewart; Ka Y Yuen; Sophia Hinrichsen; Elizabeth L Dryburgh; François-René Bertin
Journal:  J Vet Intern Med       Date:  2020-04-07       Impact factor: 3.333

7.  Pituitary Pars Intermedia Dysfunction and Metabolic Syndrome in Donkeys.

Authors:  Heidrun Gehlen; Bianca Schwarz; Claus Bartmann; Jennifer Gernhardt; Sabita D Stöckle
Journal:  Animals (Basel)       Date:  2020-12-08       Impact factor: 2.752

Review 8.  Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management.

Authors:  Caroline W Spelta
Journal:  Vet Med (Auckl)       Date:  2015-08-20

9.  Use of principle component analysis to quantitatively score the equine metabolic syndrome phenotype in an Arabian horse population.

Authors:  Samantha L Lewis; Heather M Holl; Maureen T Long; Martha F Mallicote; Samantha A Brooks
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

10.  Dysregulation of Cortisol Metabolism in Equine Pituitary Pars Intermedia Dysfunction.

Authors:  Ruth A Morgan; John A Keen; Natalie Homer; Mark Nixon; Anna M McKinnon-Garvin; Jodie A Moses-Williams; Sarah R Davis; Patrick W F Hadoke; Brian R Walker
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.